Jiangsu Kanion Pharmaceutical Co Ltd (600557) — Financial Flexibility Index
Jiangsu Kanion Pharmaceutical Co Ltd (600557) has a Financial Flexibility Index of 0.18x as of September 2025. Free cash flow of CN¥330.77 Million (operating CF CN¥201.83 Million minus capex CN¥128.94 Million) represents 0% of total liabilities (CN¥1.83 Billion). Check 600557 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Jiangsu Kanion Pharmaceutical Co Ltd Financial Flexibility Index (2001–2024)
Historical Financial Flexibility Index trend for Jiangsu Kanion Pharmaceutical Co Ltd across 24 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Jiangsu Kanion Pharmaceutical Co Ltd.
Annual Financial Flexibility Index for Jiangsu Kanion Pharmaceutical Co Ltd (2001–2024)
Year-by-year free cash flow to debt coverage for Jiangsu Kanion Pharmaceutical Co Ltd. Explore cash flow to debt ratio of Jiangsu Kanion Pharmaceutical Co Ltd to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.54x | CN¥1.18 Billion | CN¥702.49 Million | CN¥2.20 Billion | ▼ -26.7% |
| 2023 | 0.73x | CN¥1.27 Billion | CN¥972.32 Million | CN¥1.74 Billion | ▲ +12.8% |
| 2022 | 0.65x | CN¥1.21 Billion | CN¥995.94 Million | CN¥1.86 Billion | ▼ -7.2% |
| 2021 | 0.70x | CN¥1.08 Billion | CN¥908.30 Million | CN¥1.55 Billion | ▲ +40.5% |
| 2020 | 0.50x | CN¥891.42 Million | CN¥701.10 Million | CN¥1.79 Billion | ▼ -28.9% |
| 2019 | 0.70x | CN¥1.42 Billion | CN¥925.73 Million | CN¥2.02 Billion | ▲ +25.7% |
| 2018 | 0.56x | CN¥952.12 Million | CN¥636.39 Million | CN¥1.71 Billion | ▲ +55.6% |
| 2017 | 0.36x | CN¥643.87 Million | CN¥382.93 Million | CN¥1.80 Billion | ▼ -12.7% |
| 2016 | 0.41x | CN¥624.26 Million | CN¥299.02 Million | CN¥1.52 Billion | ▼ -34.0% |
| 2015 | 0.62x | CN¥889.59 Million | CN¥514.80 Million | CN¥1.43 Billion | ▲ +59.8% |
| 2014 | 0.39x | CN¥620.91 Million | CN¥311.54 Million | CN¥1.60 Billion | ▼ -20.0% |
| 2013 | 0.49x | CN¥727.33 Million | CN¥388.11 Million | CN¥1.50 Billion | ▲ +53.6% |
| 2012 | 0.32x | CN¥465.99 Million | CN¥212.11 Million | CN¥1.47 Billion | ▼ -8.8% |
| 2011 | 0.35x | CN¥383.72 Million | CN¥90.19 Million | CN¥1.11 Billion | ▼ -42.9% |
| 2010 | 0.61x | CN¥451.29 Million | CN¥166.40 Million | CN¥743.19 Million | ▲ +1952.0% |
| 2009 | 0.03x | CN¥10.87 Million | CN¥-21.87 Million | CN¥367.23 Million | ▼ -92.7% |
| 2008 | 0.41x | CN¥145.08 Million | CN¥58.39 Million | CN¥355.85 Million | ▲ +27.4% |
| 2007 | 0.32x | CN¥151.62 Million | CN¥92.73 Million | CN¥473.81 Million | ▲ +6.2% |
| 2006 | 0.30x | CN¥133.50 Million | CN¥108.98 Million | CN¥443.19 Million | ▲ +3.6% |
| 2005 | 0.29x | CN¥154.82 Million | CN¥101.44 Million | CN¥532.62 Million | ▼ -25.3% |
| 2004 | 0.39x | CN¥144.36 Million | CN¥21.68 Million | CN¥370.88 Million | ▲ +9.2% |
| 2003 | 0.36x | CN¥143.84 Million | CN¥17.13 Million | CN¥403.56 Million | ▼ -66.7% |
| 2002 | 1.07x | CN¥99.22 Million | CN¥11.15 Million | CN¥92.69 Million | ▲ +181.1% |
| 2001 | 0.38x | CN¥39.46 Million | CN¥21.02 Million | CN¥103.61 Million | — |